Overview

Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients

Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This study aimed to compare detection rate between dual sentinel node staining method using mixture of indocyanine green (ICG) with radioisotope(RI), and RI only. To identify the first lymph node(s) along the lymphatic drainage pathway from the primary tumor in the breast cancer using RI only has several disadvantages such as invisibility, interference. As ICG can be visualized with a fluorescence imaging system, we expects dual sentinel lymph node staining method had better outcomes.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Center, Korea